Boothbay Fund Management »

Aerovate Therapeutics shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Aerovate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aerovate Therapeutics held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aerovate Therapeutics by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.9M 98k 29.57
2023-03-31 $798k 40k 20.17
2022-12-31 $756k 26k 29.30
2022-09-30 $593k 36k 16.58

More positions owned by Boothbay Fund Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ishares Bitcoin Tr SHS
Fidelity Wise Origin Bitcoin SHS
Grayscale Bitcoin Tr Btc Shs Rep Com Ut (GBTC)
Microstrategy Cl A New Put Option (MSTR)
Bitwise Bitcoin Etf Tr Shs Ben Int
Sarepta Therapeutics Put Option (SRPT)
Spdr Ser Tr S&p Biotech Put Option (XBI)
United States Steel Corporation (X)
NVIDIA Corporation Call Option (NVDA)
Cornerstone Strategic Value (CLM)
Amazon Put Option (AMZN)
Humana Call Option (HUM)
Amphenol Corp Cl A Put Option (APH)

View all positions for Boothbay Fund Management

Top funds holding Aerovate Therapeutics

RA Capital Management
Sofinnova Ventures
TCG Crossover Management
Atlas Venture Life Science Advisors
Baker Bros. Advisors
Frazier Life Sciences Management
Cormorant Asset Management
Dr. Jeffrey R. Jay, M.D.
Driehaus Capital Management
BlackRock
Vanguard Group
OrbiMed Advisors
FMR
Eventide Asset Management
Octagon Capital Advisors

View all funds holding Aerovate Therapeutics